FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034683735> ?p ?o ?g. }

• W2034683735 endingPage "4736" @default.
• W2034683735 startingPage "4727" @default.
• W2034683735 abstract "To evaluate immunogenicity, reactogenicity, and safety of a hexavalent combination vaccine diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b (DTPa-HBV-IPV/Hib) when coadministered with a 7-valent pneumococcal conjugate vaccine (PCV7).Infants received either a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-H. influenzae type b vaccine concomitantly with PCV7 or DTPa-HBV-IPV/Hib alone infants were vaccinated at 2, 3 and 4 months (primary immunization) and 12-15 months of age (booster dose). Local and systemic reactions and adverse events were monitored following each dose and compared between groups. Blood was obtained prior to dose 1, one month after dose 3, immediately prior to and 1 month following the booster dose to measure antibody responses to each of the antigens.Two hundred and fifty-three subjects (PCV7, 127; Control, 126) were enrolled. Antibody responses were compared in 226 subjects for the primary immunization and 212 for the booster dose (per-protocol (PP) population). Although there were some differences in geometric mean concentrations (GMCs) to the DTPa-HBV-IPV/Hib antigens after the primary series, GMCs for all antigens after the booster dose were similar in both groups, except for diphtheria which was significantly higher in the PCV7 group (PCV7, 7.41 IU/mL; Control, 5.78 IU/mL). Reactogenicity and safety data were compared in 252 infants receiving primary immunization and 235 children receiving the booster dose. Site reactions were similar in both groups. Fever >or=38.0 degrees C following each vaccination was reported more frequently in the PCV7 group (28.3-50.0%) than in the Control group (15.6-33.6%) whereas fever >39.0 degrees C occurred only in a few cases and to the same extent in both groups (PCV7, 0.8-2.7%; Control, 1.6-4.1%). Only one reported serious adverse event was characterized as being related to the study vaccines: control subject was hospitalized with a fever.DTPa-HBV-IPV/Hib and PCV7 were highly immunogenic, well-tolerated and safe when coadministered at 2, 3 and 4 months of age with a booster dose at 12-15 months of age. These results support the coadministration of PVC7 with DTPa-HBV-IPV/Hib as part of the routine immunization schedule for infants and children." @default.
• W2034683735 created "2016-06-24" @default.
• W2034683735 creator A5002387175 @default.
• W2034683735 creator A5017838321 @default.
• W2034683735 creator A5028693741 @default.
• W2034683735 creator A5044186217 @default.
• W2034683735 creator A5087695836 @default.
• W2034683735 date "2006-05-29" @default.
• W2034683735 modified "2023-10-01" @default.
• W2034683735 title "Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants" @default.
• W2034683735 cites W1608163562 @default.
• W2034683735 cites W1677285233 @default.
• W2034683735 cites W1965206227 @default.
• W2034683735 cites W1975895814 @default.
• W2034683735 cites W1979103555 @default.
• W2034683735 cites W1993540791 @default.
• W2034683735 cites W1994306618 @default.
• W2034683735 cites W2011540552 @default.
• W2034683735 cites W2021558256 @default.
• W2034683735 cites W2023690749 @default.
• W2034683735 cites W2035842331 @default.
• W2034683735 cites W2036814749 @default.
• W2034683735 cites W2044123277 @default.
• W2034683735 cites W2048765957 @default.
• W2034683735 cites W2051039256 @default.
• W2034683735 cites W2057685343 @default.
• W2034683735 cites W2066826294 @default.
• W2034683735 cites W2075208494 @default.
• W2034683735 cites W2101291113 @default.
• W2034683735 cites W2109136156 @default.
• W2034683735 cites W2129245598 @default.
• W2034683735 doi "https://doi.org/10.1016/j.vaccine.2006.03.032" @default.
• W2034683735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16616973" @default.
• W2034683735 hasPublicationYear "2006" @default.
• W2034683735 type Work @default.
• W2034683735 sameAs 2034683735 @default.
• W2034683735 citedByCount "81" @default.
• W2034683735 countsByYear W20346837352012 @default.
• W2034683735 countsByYear W20346837352013 @default.
• W2034683735 countsByYear W20346837352014 @default.
• W2034683735 countsByYear W20346837352015 @default.
• W2034683735 countsByYear W20346837352016 @default.
• W2034683735 countsByYear W20346837352017 @default.
• W2034683735 countsByYear W20346837352018 @default.
• W2034683735 countsByYear W20346837352019 @default.
• W2034683735 countsByYear W20346837352020 @default.
• W2034683735 countsByYear W20346837352023 @default.
• W2034683735 crossrefType "journal-article" @default.
• W2034683735 hasAuthorship W2034683735A5002387175 @default.
• W2034683735 hasAuthorship W2034683735A5017838321 @default.
• W2034683735 hasAuthorship W2034683735A5028693741 @default.
• W2034683735 hasAuthorship W2034683735A5044186217 @default.
• W2034683735 hasAuthorship W2034683735A5087695836 @default.
• W2034683735 hasConcept C12590561 @default.
• W2034683735 hasConcept C147483822 @default.
• W2034683735 hasConcept C159047783 @default.
• W2034683735 hasConcept C203014093 @default.
• W2034683735 hasConcept C22070199 @default.
• W2034683735 hasConcept C2522874641 @default.
• W2034683735 hasConcept C2777382497 @default.
• W2034683735 hasConcept C2777704310 @default.
• W2034683735 hasConcept C2778866548 @default.
• W2034683735 hasConcept C2779583294 @default.
• W2034683735 hasConcept C2779592421 @default.
• W2034683735 hasConcept C2779841045 @default.
• W2034683735 hasConcept C2780572238 @default.
• W2034683735 hasConcept C2780593183 @default.
• W2034683735 hasConcept C2780801004 @default.
• W2034683735 hasConcept C2780868878 @default.
• W2034683735 hasConcept C2781253189 @default.
• W2034683735 hasConcept C501593827 @default.
• W2034683735 hasConcept C71924100 @default.
• W2034683735 hasConcept C86803240 @default.
• W2034683735 hasConcept C89423630 @default.
• W2034683735 hasConceptScore W2034683735C12590561 @default.
• W2034683735 hasConceptScore W2034683735C147483822 @default.
• W2034683735 hasConceptScore W2034683735C159047783 @default.
• W2034683735 hasConceptScore W2034683735C203014093 @default.
• W2034683735 hasConceptScore W2034683735C22070199 @default.
• W2034683735 hasConceptScore W2034683735C2522874641 @default.
• W2034683735 hasConceptScore W2034683735C2777382497 @default.
• W2034683735 hasConceptScore W2034683735C2777704310 @default.
• W2034683735 hasConceptScore W2034683735C2778866548 @default.
• W2034683735 hasConceptScore W2034683735C2779583294 @default.
• W2034683735 hasConceptScore W2034683735C2779592421 @default.
• W2034683735 hasConceptScore W2034683735C2779841045 @default.
• W2034683735 hasConceptScore W2034683735C2780572238 @default.
• W2034683735 hasConceptScore W2034683735C2780593183 @default.
• W2034683735 hasConceptScore W2034683735C2780801004 @default.
• W2034683735 hasConceptScore W2034683735C2780868878 @default.
• W2034683735 hasConceptScore W2034683735C2781253189 @default.
• W2034683735 hasConceptScore W2034683735C501593827 @default.
• W2034683735 hasConceptScore W2034683735C71924100 @default.
• W2034683735 hasConceptScore W2034683735C86803240 @default.
• W2034683735 hasConceptScore W2034683735C89423630 @default.
• W2034683735 hasIssue "22" @default.
• W2034683735 hasLocation W20346837351 @default.
• W2034683735 hasLocation W20346837352 @default.

• next